RISING STARS: Targeting premature cellular senescence using senomorphic or senolytic agents to impact diabetes in: Journal of Molecular Endocrinology Volume 75 Issue 4 (2025) US$ 27.81 Min. order: 1 piece ★★★★★ 5.0 (112 reviews) Sold : Login>>
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 22.88 Min. order: 1 piece ★★★★★ 4.6 (174 reviews) Sold : Login>>
Buy GHK-Cu 50mg | 99% Purity | Made in USA US$ 22.58 Min. order: 1 piece ★★★★★ 4.4 (180 reviews) Sold : Login>>
Senotherapy for chronic lung disease US$ 29.07 Min. order: 1 piece ★★★★★ 4.9 (296 reviews) Sold : Login>>
Figure 4 — FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice US$ 20.48 Min. order: 1 piece ★★★★★ 4.5 (244 reviews) Sold : Login>>